Insulet Corporation announced the commercial availability of its Omnipod 5 Automated Insulin Delivery System in Italy, Denmark, Finland, Norway, and Sweden. This expansion brings the total number of international markets for Omnipod 5 to 13.
The system is available with compatibility for both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring sensors. This dual sensor compatibility offers greater flexibility for prescribers and patients in these new regions.
This significant international expansion broadens Insulet's global market reach and is expected to drive increased revenue from new customer starts and conversions to Omnipod 5. Offering compatibility with two leading CGM sensor brands provides greater flexibility for prescribers and patients, enhancing adoption in these new markets.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.